The CXCL5-neutralizing antibody significantly reduced MDA-PATC 148 and BxPC-3 cell–induced histone H3 citrullination, NET formation, and cancer cell invasion (Figure 6, A, B, D, and E). Here, CXCL5 is linked to cancer.